Table 1.
List of candidate datasets for the analyses.
| STUDY | YEAR | DATASET NAME | ADC & SCC | SCC+SURVIVAL | ADC+SURVIVAL | ADC >20 & SCC >20 |
|---|---|---|---|---|---|---|
| Larsen et al.55 | 2007 | Lung_Larsen_2007_A | N | Y | N | N |
| Larsen et al.56 | 2007 | Lung_Larsen_2007_B | N | N | Y | N |
| Kuner et al.57 | 2009 | Lung_Kuner_2009 | Y | N* | Y | N |
| Bild et al.58 | 2006 | Lung_Bild_2006 | Y | Y | Y | Y |
| Hou et al.34 | 2010 | Lung_Hou_2010 | Y | Y | Y | Y† |
| Tomida et al.59 | 2009 | Lung_Tomida_2009 | N | N | Y | N |
| Baty et al.60 | 2010 | Lung_Baty_2010 | Y | Y | Y | N |
| Matsuyama et al.61 | 2011 | Lung_Matsuyama_2011 | Y | Y | Y | Y |
| Bhattacharjee et al.62 | 2001 | Lung_Bhattacharjee_2001 | Y | N | Y | Y |
| Raponi et al.63 | 2006 | Lung_Raponi_2006 | N | Y | N | N |
| Shedden et al.64 | 2008 | Lung_Shedden_2008 | N | N | Y | N |
| Zhu et al.65 | 2010 | Lung_Zhu_2010 | Y | Y | Y | Y |
| Girard et al.66 | 2011 | Lung_Girard_2011 | N | N | N* | N |
| Jones et al.67 | 2004 | Lung_Jones_2004 | N | N | N* | N |
| Moriya et al.68 | 2007 | Lung_Moriya_2007 | Y | N | N | N |
| Wright et al.69 | 2010 | Lung_Wright_2010 | N | N | Y | N |
| Ding et al.70 | 2008 | Lung_Ding_2008 | Y | N | N | N |
| Lee et al.71 | 2008 | Lung_Lee_2008 | Y | Y | Y | Y |
| Curley et al.72 | 2005 | ExpO | Y | N | N | Y |
| Dehan et al.73 | 2007 | Lung_Dehan_2007 | Y | N | N | N |
| Fujiwara et al.74 | 2012 | Lung_Fujiwara_2012 | Y | N | N‡ | N |
Notes:
*
Survival data for the corresponding cancer subtype exist, but for either high CDKN3 or low CDKN3 group there are no deceased patients and thus the Cox proportional hazard model is not applicable.
†
More than 20 patients have normal samples.
‡
Only one patient has survival time information.